Last Updated: March 16, 2026
Understanding Compounded Medications and FDA Approval
Compounded medications occupy a distinct place in U.S. healthcare — legally regulated, clinically necessary, but frequently misunderstood. This article explains how compounding works, how these medications are regulated, what risks to evaluate, and how clinically managed protocols address those risks in the context of compounded ketamine therapy.

Key takeaways
- Compounded medications do not undergo the FDA's premarket review process for safety and effectiveness, though they remain a legally regulated component of U.S. healthcare.
- The FDA oversees 503B outsourcing facilities directly, while state boards of pharmacy primarily regulate traditional 503A compounding pharmacies using United States Pharmacopeia (USP) quality standards.
- In a peer-reviewed Mindbloom study of 11,441 patients receiving clinically managed at-home compounded ketamine therapy, serious adverse events occurred in fewer than 0.1% of sessions.
- Active ingredients used in compounded medications, such as ketamine, often have decades of established clinical history and FDA approval in their commercially manufactured forms.
What Are Compounded Medications?
Compounded medications are custom-prepared drugs mixed by a licensed pharmacist to meet your specific medical needs. This process differs from standard pharmaceutical manufacturing, which produces uniform doses for the general public.
Clinicians prescribe compounded drugs when a commercially available medication cannot meet your unique requirements. Understanding what is a compounding pharmacy helps clarify why these customized medications are a standard part of the healthcare system.
Pharmacists create these medications by combining active pharmaceutical ingredients with inactive ingredients like flavorings or bases. Common reasons for pharmacy compounding include:
- Allergy or sensitivity: You cannot tolerate an inactive ingredient, such as a specific dye or chemical preservative, found in the mass-produced version.
- Dosage form change: You require a liquid suspension because you cannot swallow a solid tablet, or you need a topical cream instead of an oral pill.
- Drug shortage: When a medication appears on the FDA’s official drug shortage list, compounding pharmacies may temporarily produce versions of that drug to help maintain patient access.
- Discontinued medications: The commercially manufactured product is no longer produced by pharmaceutical companies, but you still need the treatment.
- Pediatric or geriatric dosing: Standard adult doses are not appropriate or safe for a specific patient's age, weight, or metabolism.
The difference between compounding and regular pharmacies lies in how medications are sourced and prepared. Traditional compounding pharmacies, known as 503A compounding facilities, fill individual prescriptions for specific patients.
Outsourcing facilities, known as 503B facilities, can produce larger batches of medications without patient-specific prescriptions. These larger facilities must register directly with the FDA and follow current good manufacturing practice requirements.
Compounding has been a foundational part of pharmacy practice for centuries and remains a routine clinical tool today.[10] Organizations like the American Pharmacists Association recognize compounding as a legitimate, necessary component of patient care.
Are Compounded Drugs FDA Approved?
No, compounded medications are not FDA-approved. While the active pharmaceutical ingredients used in the formulation may be FDA-approved, the final customized product does not undergo the FDA's premarket review process.
The FDA approval process requires a drug manufacturer to submit extensive clinical trial data demonstrating safety and efficacy. The FDA reviews this data over several years, and if approved, the commercially manufactured drug can be marketed with specific, standardized labeling.
Compounded drugs are prepared for individual patients based on a clinician's specific prescription. Because each formulation is customized for a single person, it is impossible to submit every unique preparation through this multi-year approval pipeline. FDA approval processes are designed for drugs that are manufactured at scale and distributed widely, not individualized formulations prepared for a single patient at a time.
The absence of FDA approval does not make a compounded medication inherently unsafe — particularly when the active ingredient, such as ketamine, has a well-established safety profile. It simply means the responsibility for quality assurance falls on the compounding pharmacy, the prescribing clinician, and state regulatory oversight.
How Does FDA Approval Differ From FDA Regulation?
While compounded drugs are not FDA-approved, compounding pharmacies are not entirely outside of FDA regulation. The FDA actively inspects compounding facilities, issues warning letters, and takes enforcement action against pharmacies that violate federal law.
The agency also maintains a strict list of drugs that have been withdrawn from the market for safety reasons. Pharmacies cannot legally compound any medication using these prohibited ingredients.
Are Any Compounded Drugs FDA Approved?
By definition, no compounded drugs are FDA-approved, because any drug that completes the approval process becomes a commercially manufactured product. However, many compounded drugs use the exact same active ingredients found in FDA-approved products.
For example, ketamine has been FDA-approved as an anesthetic since 1970 and has been on the World Health Organization's List of Essential Medicines since 1985. When ketamine is compounded into sublingual tablets for therapeutic use, the active ingredient's decades-long clinical history provides a strong foundation of evidence.
Who Regulates Compounding Pharmacies?
The regulatory landscape for compounding pharmacies involves three primary entities working together. State boards of pharmacy, the FDA, and the United States Pharmacopeia each play a distinct role in maintaining quality standards.
State boards of pharmacy serve as the primary regulators for traditional 503A compounding pharmacies. They license pharmacists, conduct facility inspections, and enforce state-specific compounding regulations to protect public health.
The FDA maintains direct oversight of 503B outsourcing facilities. These larger operations must register with the agency, report adverse events, and comply with strict manufacturing requirements.
The United States Pharmacopeia establishes the quality benchmarks that state boards enforce across the country.[4] These standards dictate how medications must be handled, mixed, and stored.
Key United States Pharmacopeia standards include:
- USP Chapter <795>: This standard governs non-sterile compounding practices, setting rules for ingredient selection, equipment cleaning, and beyond-use dating.
- USP Chapter <797>: This standard governs sterile compounding, setting strict rules for environmental controls, air quality, and personnel training.
The compounding quality act of 2013 formalized this regulatory framework following the tragic 2012 New England Compounding Center meningitis outbreak.[5] Under new compounding pharmacy regulations, a compounded medication prescribed by a licensed clinician operates within a defined legal framework.
What Are the Risks of Compounded Medications?
The primary risks associated with compounded medications include potency variability, potential contamination, incorrect labeling, and a lack of standardized post-market testing.[2] The FDA and clinical literature consistently identify these areas as the main safety considerations for patients.
Without the batch-to-batch consistency testing required of FDA-approved manufacturers, compounded drugs may contain slightly more or less active ingredient than intended. This potency variability can affect therapeutic efficacy or cause unexpected effects during treatment.
Sterile compounded products, such as injectables or eye drops, carry a risk of microbial contamination if environmental controls or testing protocols are inadequate. Compounded drugs may also lack the detailed patient information inserts that accompany FDA-approved products.
Furthermore, FDA-approved drugs are subject to ongoing adverse event reporting systems managed by the federal government. Compounded drugs from traditional 503A pharmacies do not have this same mandatory reporting infrastructure.
When asking are compounding pharmacies safe, the answer depends heavily on the specific pharmacy's practices and the regulatory environment. A well-run compounding pharmacy operating under updated United States Pharmacopeia standards presents a very different risk profile than an uninspected facility.
You can ask your prescribing clinician or pharmacy specific questions to verify quality:
- USP compliance: Does the pharmacy strictly follow USP <795> and <797> guidelines for preparation and storage?
- Third-party testing: Does the facility use independent laboratories to verify the potency and sterility of their products?
- Accreditation: Is the pharmacy accredited by recognized organizations like the Pharmacy Compounding Accreditation Board?
Can You Buy Compounded Medications Online?
You can legally purchase compounded medications online, provided you have a valid prescription from a licensed clinician and the medication comes from a licensed pharmacy. In this context, "buying online" typically means a telehealth clinician evaluates you, writes a prescription, and a pharmacy ships the medication to your home.
The expansion of telehealth has made online access to compounded medications more common across the country. This operates within the same regulatory framework as in-person prescriptions when managed by licensed medical professionals.
However, the FDA frequently warns consumers about purchasing compounded drugs from unverified online sources that bypass clinical oversight. To ensure safety and legitimacy, you must verify several elements before obtaining compounded medications through an online platform.
Look for these safety indicators when evaluating an online provider:
- Valid prescription requirement: The provider must require a comprehensive clinical evaluation before prescribing any medication.
- Licensed pharmacy: The dispensing compounding pharmacy must be licensed in your state and registered appropriately.
- Clinician oversight: A licensed medical professional must be actively involved in your ongoing care, not just during a transactional checkout process.
- NABP verification: The pharmacy should ideally appear in the National Association of Boards of Pharmacy's verified database.[6]
The online channel itself is not the primary risk factor when seeking medical treatment. Compounded medications obtained through a clinically managed program are fundamentally different from products purchased from unverified websites.
How Clinically Managed Protocols Reduce Risk in Compounded Ketamine Therapy
Clinically managed protocols are defined systems of screening, prescribing, monitoring, and follow-up designed to ensure patient safety. This clinical framework bridges the gap between a medication lacking premarket FDA approval and the delivery of safe, appropriate care.
Responsible providers manage the inherent variability of compounded medications through rigorous clinical oversight. This approach prioritizes patient safety at every step of the treatment process.
This protocol-driven framework includes several critical safety elements:
- Clinical screening: A licensed clinician evaluates your medical history, cardiovascular health, and psychiatric background to determine if ketamine therapy is medically appropriate.
- Pharmacy vetting: Providers partner exclusively with compounding pharmacies that meet strict quality standards, including USP compliance and third-party testing.
- Clinician-determined dosing: Prescribing clinicians determine sub-anesthetic, therapeutic doses based on individual clinical factors, rather than relying on a one-size-fits-all approach.
- Required peer treatment monitor: A designated adult must be physically present during every session to ensure safety and provide support.
- Ongoing clinical monitoring: Follow-up consultations allow the clinician to assess your response, adjust dosing, and evaluate for any adverse effects.
Building on decades of clinical research supporting ketamine's therapeutic applications, Mindbloom has published two of the largest peer-reviewed, real-world outcomes studies of at-home ketamine therapy to date. These studies were conducted on Mindbloom clients using the Mindbloom clinical protocol.
Mindbloom's care model includes clinician consults, guide coaching, unlimited Group Integration Circles, and a required peer treatment monitor. Mindbloom is also the only at-home ketamine provider offering both sublingual tablets and subcutaneous injectables.
This defined treatment framework allows the clinician to determine the most appropriate administration route for consistent dosing.
The Bottom Line on Compounded Medications and FDA Approval
Compounded medications are not FDA-approved, but they remain a legal, regulated, and clinically necessary part of the U.S. healthcare system. The absence of premarket FDA review means that medication quality depends heavily on the compounding pharmacy's practices.
For patients using compounded medications, including compounded ketamine for therapeutic purposes, safety relies on the quality of the clinical program surrounding the medication.[8] Always discuss any questions about compounded medications, pharmacy standards, or treatment protocols directly with your prescribing clinician.
Disclaimer and Safety Information
IMPORTANT SAFETY INFORMATION
Ketamine is not FDA-approved for PTSD, depression, or anxiety. Common side effects include dissociation, increased blood pressure, nausea, dizziness, and cognitive impairment. Ketamine has abuse potential and is not appropriate for patients with uncontrolled hypertension, psychotic disorders, or substance use disorders. Do not drive or operate machinery until the day after treatment. Individual results may vary. Full safety information: www.mindbloom.com/safety-information
OFF-LABEL USE DISCLOSURE
Ketamine is FDA-approved only as an anesthetic. Use for mental health conditions represents off-label prescribing by licensed clinicians based on clinical judgment. Schedule III Controlled Substance - DEA regulations apply.
Frequently asked questions
Are compounded medications safe to take?
Compounded medications can be safe when prescribed by a licensed clinician and prepared by a highly regulated, USP-compliant compounding pharmacy. Safety depends heavily on the clinical oversight and the specific quality control measures of the dispensing facility.
Why would a doctor prescribe a compounded medication?
Clinicians prescribe compounded medications when commercially available, FDA-approved drugs cannot meet a patient's specific medical needs. This often occurs due to ingredient allergies, the need for a different dosage form, or national drug shortages.
Does insurance cover compounded medications?
Insurance coverage for compounded medications varies widely depending on your specific health plan and the prescribed ingredients. Many plans require prior authorization or may only cover the cost of the active pharmaceutical ingredients rather than the compounding process itself.
How can I tell if a compounding pharmacy is legitimate?
You can verify a compounding pharmacy's legitimacy by checking its license status with your state's board of pharmacy. You can also look for accreditations from recognized organizations like the Pharmacy Compounding Accreditation Board.
What is the difference between a 503A and 503B pharmacy?
A 503A pharmacy prepares custom medications for individual patients based on specific prescriptions from a clinician. A 503B outsourcing facility can manufacture larger batches of compounded drugs for healthcare facilities and is subject to direct FDA oversight.
Can I get compounded ketamine for depression?
Yes, if a licensed clinician determines it is medically appropriate, they can prescribe compounded ketamine for depression as an off-label treatment.[11] This should always be done within a clinically managed framework, such as <a href="https://www.mindbloom.com/at-home-ketamine">at-home ketamine therapy</a>, that includes thorough screening and ongoing monitoring.
Do compounded drugs expire faster than regular drugs?
Compounded medications typically have shorter expiration dates, known as beyond-use dates, compared to commercially manufactured drugs. Because they lack the extensive stability testing of mass-produced pharmaceuticals, they must be used within a specific timeframe to ensure potency and safety.

Mindbloom Treatment
See what might be possible with clinician-guided, at-home ketamine therapy. New client programs start at $165 per session.






